Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

25.96 +0.09 (+0.35%)
Official Closing Price Updated: 4:10 PM EDT, May 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 39,373,775
Open 25.80
Bid (Size) 25.93 (300)
Ask (Size) 25.95 (1,000)
Prev. Close 25.87
Today's Range 25.64 - 26.09
52wk Range 21.97 - 28.75
Shares Outstanding 5,606,688,356
Dividend Yield 6.63%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Valneva Q1 Earnings Call Highlights ↗
Valneva (NASDAQ:VALN) reported lower first-quarter revenue and a wider loss for 2026, while management said the company is focused on conserving cash as it awaits the next regulatory steps for its Lyme... 
Via MarketBeat
Topics Earnings
News headline image
These Analysts Increase Their Forecasts On Arvinas After Q1 Results ↗
Arvinas Inc (NASDAQ:ARVN) reported Q1 losses of 90 cents/share, missed analyst estimates. Rigel Pharmaceuticals (NASDAQ:RIGL) announced global licensing agreement with Arvinas and Pfizer (NYSE:PFE) for... 
Via Benzinga

Performance

YTD
+3.1%
+3.1%
1 Month
-5.0%
-5.0%
3 Month
-6.0%
-6.0%
6 Month
+1.8%
+1.8%
1 Year
+12.4%
+12.4%

More News

Read More
News headline image
3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally ↗
Via The Motley Fool
News headline image
3 Struggling Stocks That Could Make for Great Contrarian Buys ↗
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
News headline image
European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors
From Pfizer Inc.
Via Business Wire
News headline image
The Top 5 Analyst Questions From Novavax’s Q1 Earnings Call
Via StockStory
Topics Earnings
News headline image
Rigel Pharmaceuticals Inks Breast Cancer Drug Deal With Arvinas, Pfizer ↗
Via Benzinga
News headline image
Prediction: Pfizer Will Beat the Market Over the Next 5 Years ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Up 373%, Is ExxonMobil Proving Why It Was a Mistake for Salesforce to Replace ExxonMobil in the Dow Jones Industrial Average? ↗
Via The Motley Fool
Topics Stocks
News headline image
Arvinas Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
Via FinancialNewsMedia
News headline image
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
From MarketNewsUpdates.com
Via GlobeNewswire
News headline image
Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)
From Arvinas Inc.
Via GlobeNewswire
News headline image
Is Pfizer a Buy, Sell, or Hold in 2026? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Pfizer's Net Income Drops in Q1. Is Its Dividend Still Safe? ↗
Via The Motley Fool
News headline image
5 Must-Read Analyst Questions From Pfizer’s Q1 Earnings Call
Via StockStory
Topics Earnings
News headline image
Is This a Sign Pfizer's Aggressive Growth Strategy Is Paying Off? ↗
Via The Motley Fool
Topics Intellectual Property
BioMedNewsBreaks — SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advances Next-Generation GLP-1 Candidate as Obesity Drug Market Expands Rapidly
Via Investor Brand Network
News headline image
The Next Generation of the GLP-1 Revolution Is Already Underway
From BioMedWire
Via GlobeNewswire
News headline image
3 Unprofitable Stocks That Fall Short
Via StockStory
News headline image
Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Healthcare Stocks Every Retiree Should Consider ↗
Via The Motley Fool
Topics Intellectual Property Retirement
News headline image
Got $5,000 to Invest in a Volatile Market? Here's Exactly Where I'd Put It. ↗
Via The Motley Fool
Topics Economy
What Are Horizontal Mergers and Acquisitions?
Via BusinesNews Wire
Topics Economy
News headline image
GoodRx (GDRX) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings

Frequently Asked Questions

Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 25.96
When was Pfizer last traded?
The last trade of Pfizer was at 05/13/26 04:10 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 145.55B
How many shares of Pfizer are outstanding?
Pfizer has 146B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.